Literature DB >> 24637364

Rheumatoid arthritis: treating cardiovascular risk in RA requires multidisciplinary care.

Rekha Mankad1, Sherine E Gabriel2.   

Abstract

Rheumatoid arthritis is associated with an excess risk of cardiovascular disease, but current cardiovascular risk models might not be adequate to fully predict individual risk in a patient with this disease. Does the solution lie in closer collaboration between rheumatologists and cardiologists?

Entities:  

Mesh：

Year:  2014        PMID： 24637364     DOI： 10.1038/nrrheum.2014.37

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

Review 1.  Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.

Authors:  Naveed Sattar; David W McCarey; Hilary Capell; Iain B McInnes
Journal:  Circulation       Date:  2003-12-16       Impact factor: 29.690

Review 2.  AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease.

Authors:  Vincent E Friedewald; Peter Ganz; Joel M Kremer; Philip J Mease; James R O'Dell; Thomas A Pearson; C Venkata S Ram; Paul M Ridker; Jane E Salmon; William C Roberts
Journal:  Am J Cardiol       Date:  2010-08-01       Impact factor: 2.778

Review 3.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 4.  Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.

Authors:  James H Stein; Claudia E Korcarz; R Todd Hurst; Eva Lonn; Christopher B Kendall; Emile R Mohler; Samer S Najjar; Christopher M Rembold; Wendy S Post
Journal:  J Am Soc Echocardiogr       Date:  2008-02       Impact factor: 5.251

5.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

Authors:  E E A Arts; C Popa; A A Den Broeder; A G Semb; T Toms; G D Kitas; P L van Riel; J Fransen
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

6.  Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

Authors:  Hyon K Choi; Miguel A Hernán; John D Seeger; James M Robins; Frederick Wolfe
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

Review 7.  Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis.

Authors:  Pascal N Tyrrell; Joseph Beyene; Brian M Feldman; Brian W McCrindle; Earl D Silverman; Timothy J Bradley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

8.  Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.

Authors:  Cynthia S Crowson; Eric L Matteson; Veronique L Roger; Terry M Therneau; Sherine E Gabriel
Journal:  Am J Cardiol       Date:  2012-04-20       Impact factor: 2.778

Review 9.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Cynthia S Crowson; Katherine P Liao; John M Davis; Daniel H Solomon; Eric L Matteson; Keith L Knutson; Mark A Hlatky; Sherine E Gabriel
Journal:  Am Heart J       Date:  2013-08-29       Impact factor: 4.749

Review 10.  Mortality in rheumatoid arthritis: 2008 update.

Authors:  T Sokka; B Abelson; T Pincus
Journal:  Clin Exp Rheumatol       Date:  2008 Sep-Oct       Impact factor: 4.473
  10 in total
  1 in total

Review 1.  Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.

Authors:  Justin C Mason; Peter Libby
Journal:  Eur Heart J       Date:  2014-11-27       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.